Safi R. Bahcall, President and CEO at SYNTA PHARMACEUTICALS CORP (SNTA), bought 10,000 shares at $5.34 ($53K) on 2012-06-29, disclosed to the SEC on 2012-07-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SNTA | BUY | 2013-06-24 | $82K | — | Filing → |
| SNTA | BUY | 2013-06-17 | $41K | — | Filing → |
| SNTA | BUY | 2013-06-06 | $40K | — | Filing → |